Dual gene therapy with SERCA1 and Kir2.1 abbreviates excitation without suppressing contractility
J. Clin. Invest. Irene L. Ennis, et al. 109:393
doi:10.1172/JCI13359 [Go to this article.]

Problems with a PDF?